NCT00695435View on ClinicalTrials.gov

Tobramycin Tear Concentrations

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2008

Conditions
Dry Eye
Interventions
DRUG

TOBRADEX Ophthalmic Suspension

TOBRADEX Ophthalmic Suspension 1 drop each eye at baseline

DRUG

Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension

Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension 1 drop each eye at baseline

DRUG

TOBREX Ophthalmic Solution

TOBREX Ophthalmic Solution 1 drop each eye at baseline

Trial Locations (1)

76134

Contact Alcon Call Center For Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY